Literatur
Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664
Bujold A, Massey CA, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639
Dawson LA, Eccles C, Craig T (2006) Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856–864
Feng M, Ben-Josef E (2011) Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol 21:271–277
Mendez Romero A, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i–ii study. Acta Oncol 45:831–837
Cárdenes HR, Price TR, Perkins SM et al (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12:218–225
Liang SX, Zhu XD, Xu ZY et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65:426–434
Xu ZY, Liang SX, Zhu J et al (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65:189–195
Skinner HD, Sharp HJ, Kaseb AO et al (2011) Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50:1191–1198
Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81:e447–e453
Habermehl D, Debus J, Ganten T et al (2013) Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response. Radiat Oncol 8:59
Combs SE, Habermehl D, Ganten T et al (2011) Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial. BMC Cancer 11:67
Einhaltung ethischer Richtlinien
Interessenkonflikt. D. Habermehl und S.E. Combs geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Habermehl, D., Combs, S. Stereotaktisch geführte Radiotherapie beim lokal fortgeschrittenen hepatozellulären Karzinom. Strahlenther Onkol 189, 1051–1053 (2013). https://doi.org/10.1007/s00066-013-0449-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-013-0449-4